A German company already testing a vaccine against tuberculosis will include efficacy against COVID-19
https://www.mpg.de/14610776/immune-boost-corona-virus
There's little details on why, but the vaccine seems to give some broad protection to a variety of viral infections in the respiratory system. Interestingly, this drug is based on an old TB vaccine, BCG. BCG is still routinely given out in South Korea because South Korea, for some reason, still has a high occurrence rate of TB. If BCG does offer some protection, it may help explain why their death and infection rates are lower. This isn't too far of a stretch as Harvard and two Dutch universities are starting to test BCG against COV-ID.
It seems like a little bit of a long shot, but if there is protection, since the trial is in Phase III, it may shorten the time to market to a few months instead of 12-18 months.
https://www.mpg.de/14610776/immune-boost-corona-virus
There's little details on why, but the vaccine seems to give some broad protection to a variety of viral infections in the respiratory system. Interestingly, this drug is based on an old TB vaccine, BCG. BCG is still routinely given out in South Korea because South Korea, for some reason, still has a high occurrence rate of TB. If BCG does offer some protection, it may help explain why their death and infection rates are lower. This isn't too far of a stretch as Harvard and two Dutch universities are starting to test BCG against COV-ID.
It seems like a little bit of a long shot, but if there is protection, since the trial is in Phase III, it may shorten the time to market to a few months instead of 12-18 months.